AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 22 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $799,000 | -19.1% | 115,156 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $988,000 | +14.4% | 115,156 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $864,000 | +12.6% | 115,156 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $767,000 | -28.9% | 115,156 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,079,000 | -26.4% | 115,156 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,466,000 | – | 115,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |